The Swiss government is due to meet this week with pharmaceuticals firms that U.S. President Donald Trump has asked to lower ...

Roche (RHHBY) and Novartis (NVS) are scheduled to meet with Swiss officials this week amid U.S. tariff threats on pharma ...

The Swiss government is engaging with pharma companies Roche and Novartis to address U.S. President Trump's demand for price cuts and to negotiate a 39% tariff on Swiss exports. The discussion follows ...

The pan-European Stoxx Europe 600 index rose slightly Monday, adding to Friday's gains, as earnings season winds down and as investors looked toward economic data expected this week for fresh insight ...

European shares were broadly flat on Monday, as investors refrained from making big bets ahead of a key U.S. inflation data, ...

Switzerland’s government has reached out to local drugmakers Roche Holding AG and Novartis AG to discuss the tariff situation ...

President Trump sees Switzerland as doing too little to address its trade deficit with the U.S., a gap he focused on as he ...

Europe's pharmaceutical companies are bracing for United States President Donald Trump's plan to slap tariffs of up to 250 ...

Goods shipped from the country face a 39 percent tariff in the U.S., which companies warn will have dire consequences if ...

Trump told CNBC he will initially impose a “small tariff” on pharmas in the next week or so, but will raise it to 150% in a ...

European shares ended flat after initial gains were erased by U.S. President Trump's tariff threat on pharmaceutical imports.

After weeks of working with U.S. officials to try to avoid hefty tariffs on Swiss goods, negotiators from Switzerland got ...